Therapy insight: cardiovascular complications associated with muscular dystrophies (Q36304335)

13 August 2017

1 reference

title

Therapy insight: cardiovascular complications associated with muscular dystrophies (English)

1 reference

13 August 2017

Elizabeth M McNally

1

1 reference

13 August 2017

Heather MacLeod

series ordinal

2

1 reference

13 August 2017

publication date

1 June 2005

1 reference

Nature Clinical Practice Cardiovascular Medicine

13 August 2017

published in

1 reference

13 August 2017

volume

2

1 reference

13 August 2017

issue

6

1 reference

13 August 2017

page(s)

301-308

1 reference

Limb-girdle muscular dystrophies--from genetics to molecular pathology

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

Intermediate filaments and the function of the dystrophin-protein complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

Muscle degeneration without mechanical injury in sarcoglycan deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

Enteroviral protease 2A directly cleaves dystrophin and is inhibited by a dystrophin-based substrate analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

Smooth muscle cell-extrinsic vascular spasm arises from cardiomyocyte degeneration in sarcoglycan-deficient cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

Limb-girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the sarcomeric protein telethonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

Myotilin is mutated in limb girdle muscular dystrophy 1A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

Muscle LIM protein deficiency leads to alterations in passive ventricular mechanics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

Defective glycosylation in congenital muscular dystrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

Nuclear envelope proteins and neuromuscular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

Dysferlin is a plasma membrane protein and is expressed early in human development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

Calcium-sensitive phospholipid binding properties of normal and mutant ferlin C2 domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

Defective membrane repair in dysferlin-deficient muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

Mitosis in developing cardiac muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

Adult cardiac stem cells are multipotent and support myocardial regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

Sudden cardiac death in myotonic dystrophy type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

Systemic delivery of genes to striated muscles using adeno-associated viral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

Dystrophin expression in the mdx mouse restored by stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

Functional improvement of dystrophic muscle by myostatin blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

Heregulin ameliorates the dystrophic phenotype in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

Dystrophin protects the sarcolemma from stresses developed during muscle contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

7 January 2021

Dystrophin-deficient cardiomyocytes are abnormally vulnerable to mechanical stress-induced contractile failure and injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

7 January 2021

Tibialis anterior muscles in mdx mice are highly susceptible to contraction-induced injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

7 January 2021

Prednisolone decreases cellular adhesion molecules required for inflammatory cell infiltration in dystrophin-deficient skeletal muscle

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

7 January 2021

Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

7 January 2021

Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death?

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

7 January 2021

Calpain-3 and dysferlin protein screening in patients with limb-girdle dystrophy and myopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

7 January 2021

107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

7 January 2021

Cardiomyopathy in muscular dystrophies

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

7 January 2021

The timing between skeletal muscle myoblast replication and fusion into myotubes, and the stability of regenerated dystrophic myofibres: an autoradiographic study in mdx mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

7 January 2021

ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Gu

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

7 January 2021

Cardiac transplantation in a Duchenne muscular dystrophy carrier

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

7 January 2021

Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

7 January 2021

Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1 correlates with age and CTG repeat length

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

7 January 2021

Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

7 January 2021

ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antirrhythmia Devices: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committe

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

7 January 2021

Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0213

7 January 2021

Identifiers

DOI

10.1038/NCPCARDIO0213

1 reference

Dimensions Publication ID

13 August 2017

1033852755

0 references

1 reference